Skip to main content

Video Library

Learn about bone marrow/stem cell transplant, CAR T-cell therapy, graft-versus-host disease (GVHD), and how to manage late effects of treatment.

Categories
Tags
This presentation discusses what a clinical trial is, why they are necessary, the phases of a clinical research trials, how they are reviewed to ensure patient safety, the process involved in participating in a clinical trial, and where one can go to receive further information about clinical trials. 
This presentation outlines the importance of long-term follow-up care after a bone marrow/stem cell transplant using donor cells (allogeneic transplant) focused on supportive care for side effects post-transplant, identifying new health issues early, and providing resources and guidance to ensure the patient is experiencing their optimal quality of life after treatment.
Older age used to be a prohibitive factor for receiving a bone marrow/stem cell transplant, but this is changing. This presentation reviews the evidence that some older patients can be good candidates for transplant as well as CAR T-cell therapy and how to assess their risks.
This presentation gives a thorough description of the CAR T-cell therapy process for B-cell acute lymphoblastic leukemia (B-cell ALL), and discusses short- and long-term side effects and toxicities, expected outcomes, and ongoing research related to this therapy.
CAR T cell therapy has become an increasingly common treatment for patients with diffuse large B-cell lymphoma, (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma. This presentation discusses how it works, who is a good candidates for CAR T-cell therapy, and the risks and benefits of the treatment.
This presentation discusses CAR T-cell therapy for multiple myeloma. It explains what CAR T-cell therapy is, the process, and what clinical trials are indicating in regards to short- and long-term side effects, patient outcomes, and quality of life.
Graft-versus-host-disease (GVHD) can be a significant problem after stem cell transplantation. This presentation discusses what GVHD is, risk factors for developing it and recent advances in the prevention and treatment of GVHD.
Graft-versus-host-disease (GVHD) can be a major complication after bone marrow/stem cell transplantation. This presentation describes the types of GVHD, its typical effects on patients, and several promising new treatments for this condition.